A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.

    January 2000 in “ PubMed
    Gökhan Bayhan, M. Bahçeci, Taner Demirkol, Metin Ertem, Ahmet Yalinkaya, Erden Ac
    Image of study
    TLDR Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.
    In a study conducted 23 years ago, 60 women with idiopathic hirsutism were treated with either 5 mg of finasteride or a long-acting GnRH agonist (depot leuprolide 3.75 mg) monthly for six months. The results showed that all patients treated with either finasteride or GnRH agonist experienced no menstrual abnormalities or side-effects. The mean percent change in hirsutism scores in the GnRH and finasteride groups was 36% +/- 14% and 14% +/- 11% at six months, respectively. Serum total testosterone, free testosterone, androstenedion and DHEA-S showed a significant decrease in patients treated with GnRH agonist. However, only serum total testosterone and free testosterone levels decreased with finasteride treatment.
    View this study on pubmed.ncbi.nlm.nih.gov →


    3 / NoResults